Cybin Inc (CYBN) Granted FDA IND Clearance for its Phase 1/2a Clinical Trial of CYB003 - StreetInsider.com

Submitted by Anonymous (not verified) on Mon, 06/27/2022 - 12:01

Cybin Inc (CYBN) Granted FDA IND Clearance for its Phase 1/2a Clinical Trial of CYB003  StreetInsider.com